![]() Continuum of care for hepatitis C virus among patients diagnosed in the emergency department setting. American journal of public health, 108 (5), 591.Īnderson, E. Public health conditions for successful broad-scale integration of HIV and HCV screening in emergency departments. Annals of emergency medicine, 72 (4), 438-448.Īnderson, E. A Comparative Effectiveness Study of Two Nontargeted HIV and Hepatitis C Virus Screening Algorithms in an Urban Emergency Department. High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department. Īnderson ES, Russell C, Basham K, Montgomery M, Lozier H, Crocker A, Zuluaga M, White DAE. High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015–2017. Galbraith JW, Anderson ES, Hsieh Y, Franco RA, Donnelly JP, Rodgers JB, Schechter-Perkins EM, Thompson WW, Nelson NP, Rothman RE, White DAE. Current research projects include a pilot program evaluating the role of pre-exposure prophylaxis (PrEP) for ED patients at risk of acquiring HIV a multi-centered collaboration to further investigate rapid test diagnostics in the ED setting capacity building projects to improve linkage to care for newly-diagnosed HIV positive patients in San Francisco and Oakland and participation in a National Institutes of Health clinical trial evaluating HCV screening outcomes.įollow this link for more information about the HIV/HCV screening program. This work has resulted in over 50 abstract presentations at national meetings and 30 peer-reviewed publications. ![]() White’s research and clinical care interests are centered on advancing the diagnosis of HIV and HCV infection through integrated and streamlined ED-based testing. The screening program has received grant support from a variety of funders, including the Centers for Disease Control and Prevention, California State Office of AIDS, Gilead Sciences, and the National Institutes of Health. The HIV and HCV screening program is led by Douglas White, MD, a Highland Emergency Physician, Assistant Residency Director, and a Levitt Center Senior Scientist, who is an international authority on ED-based screening and linkage to care. Postoverdose Initiation of Buprenorphine After Naloxone-Precipitated Withdrawal Is Encouraged as a Standard Practice in the California Bridge Network of Hospitals. Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine. Strayer R, Hawk K, Hayes BD, Herring AA, Ketcham E, LaPietra AM, Lynch JJ, Motov S, Repanshek Z, Weiner SG, Nelson LS. Association of default electronic medical record settings with health care professional patterns of opioid prescribing in emergency departments: A randomized quality improvement study. Montoy JCC, Coralic Z, Herring AA, Clattenburg EJ, Raven MC. A Nonopioid, Nonbenzodiazepine Treatment Approach for Intractable Nausea and Vomiting in the Emergency Department. Valdovinos EM, Frazee BW, Hailozian C, Haro DA, Herring A. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder. Herring AA, Schultz CW, Yang E, Greenwald MK. ![]() Balancing Benefits and Harms on the Frontier of Buprenorphine Initiation. Herring, naltrexone for patients with alcohol use disorder, long acting injectable buprenorphine in the ED, and micro- and macro-dosing of buprenorphine for patients who use fentanyl.įollow these links for more information about the Highland ED Bridgea nd the California Bridge Program. There are several other additional ongoing projects related to patients with substance use disorders, including a multi-center evaluation of the California Bridge Program led by Dr. Amarinder Singh is the IT support analyst for Alameda Health System clinical sites. Nikita Joshi is the site co-I for San Leandro, and Dr. Erik Anderson is the site-PI for San Leandro Hospital, and the site co-I for Highland Hospital. Andrew Herring is a Co-Investigator for the multi-center trial, and the site-PI for Highland. The trial compares two types of treatment for patients with opioid use disorder: standard sublingual buprenorphine vs a 7-day depot injection of buprenorphine. The Alameda Health System Emergency Departments at Highland Hospital and San Leandro Hospital are sites in an NIH/NIDA funded multi-center clinical trial ED-INNOVATION led by Yale University Department of Emergency Medicine. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |